# A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

> **NCT00368030** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 545 (actual)

## Conditions studied

- Insomnia
- Depressive Disorder, Major

## Interventions

- **DRUG:** Eszopiclone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00368030
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 545 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368030, "A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00368030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*